Jim Simons Connect Biopharma Holdings LTD Call Options Transaction History
Renaissance Technologies LLC
- $63.4 Billion
- Q4 2024
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding CNTB
# of Institutions
16Shares Held
3.28MCall Options Held
0Put Options Held
0-
Bml Capital Management, LLC Zionsville, IN2.09MShares$1.93 Million1.79% of portfolio
-
Ubs Oconnor LLC Chicago, IL511KShares$469,8440.04% of portfolio
-
Choreo, LLC Minneapolis, MN161KShares$147,9970.0% of portfolio
-
Black Rock Inc. New York, NY104KShares$95,5790.0% of portfolio
-
Royal Bank Of Canada Toronto, A680.4KShares$73,9680.0% of portfolio
About Connect Biopharma Holdings Ltd
- Ticker CNTB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,015,800
- Market Cap $50.6M
- Description
- Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...